Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease

Garcia-Alloza, Monica, Robbins, Elissa M., Zhang-Nunes, Sandy X., Purcell, Susan M., Betensky, Rebecca A., Raju, Susan, Prada, Claudia, Greenberg, Steven M. +2 more·2006·Neurobiology of Disease
DOI 10.1016/j.nbd.2006.08.017

Cited by (748)

Items 601–700 of 748

  1. Deregulation of mitochondrial reverse electron transport alters the metabolism of reactive oxygen species and NAD+/NADH and presents a therapeutic target in Alzheimer’s disease
    Suman Rimal, Wen Li, Tejinder Pal Khaket, Yu Li, Ishaq Tantray, Yanping Li, Sunil Bhurtel, Lea T. Grinberg, Salvatore Spina, Inma Cobos et al. · 2024 · Ageing and Neurodegenerative Diseases
  2. Late-Stage Activation of Toll-like receptor 3 Alleviates Cognitive Impairment and Neuropathology in an Alzheimer’s Disease Mouse Model
    Taiyang Zhu, Fanyu Shen, Xiao Jia, Hui Zhou, Wanyan Ni, Shang Wang, Di Wu, Huimin Gao, Zhenying Shang, Yan Zhou et al. · 2025 · Molecular Neurobiology
  3. Progressive Neurodegeneration of Retina in Alzheimer’s Disease — Are β-Amyloid Peptide and Tau New Pathological Factors in Glaucoma?
    Kin Chiu, Kwok‐Fai So, Raymond Chuen-Chung · 2013 · InTech eBooks
  4. Spatiotemporal development of the neuronal accumulation of amyloid precursor protein and the amyloid plaque formation in the brain of 3xTg-AD mice
    Munenori Ono, Tetsufumi Ito, Sachiko Yamaki, Yoshie Hori, Qing Zhou, Xirun Zhao, Shinji Muramoto, Ryo Yamamoto, Takafumi Furuyama, Hiromi Sakata‐Haga et al. · 2024 · Heliyon
  5. Stress steroids as accelerators of Alzheimer's disease. : Effects of chronically elevated levels of allopregnanolone in transgenic AD models.
    Sara K. S. Bengtsson · 2013 · DiVA at Umeå University (Umeå University)
  6. Orally active mGluR2/3 metabotropic antagonist pro-drug mimics the beneficial effects of physical exercise on neurogenesis, behavior, and exercise-related molecular pathways in an Alzheimer’s disease mouse model
    Georgina Perez-Garcia, Mesude Bicak, Jacqueline L. Buros, Jean‐Vianney Haure‐Mirande, Gissel M. Perez, Alena Otero‐Pagan, Miguel A. Gama Sosa, Rita De Gasperi, Mary C. Sano, Fred H. Gage et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  7. Silencing of ApoE with Divalent siRNAs Drives Activation of Immune Clearance Pathways and Improves Amyloid Pathology in Mouse Models of Alzheimer’s Disease
    Chantal M. Ferguson, Samuel R. Hildebrand, Bruno M.D.C. Godinho, Julianna E. Buchwald, Dimas Echeverria, Andrew H. Coles, Anastasia P. Grigorenko, Lorenc Vanjielli, Jacquelyn Sousa, Nicholas McHugh et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  8. Synaptic and synchronic impairments in subcortical brain regions associated with early non-cognitive dysfunction in Alzheimer’s disease
    Nicolás Riffo-Lepe, Juliana González-Sanmiguel, Lorena Armijo‐Weingart, Paulina Saavedra, David Hernandez, Gerson Ramos, Loreto San Martín, Luis Gerardo Aguayo · 2025 · Neural Regeneration Research
  9. Heightened effector immune cell infiltration of the hippocampus concurrently with brain ventricular volume expansion in aged APP/PS1 mice
    Mark Andrew Maynes, Carley A. Owens, Delaney M. Wolf, Zachariah Peter Tritz, Fang Jin, Michael J. Hansen, Marina Seady, Aaron J. Johnson · 2025 · Journal of Neuroimmunology
  10. Disruption of Ca V 2.3 channels in the brain of the 5xFAD mice
    Carolina Aguado, Rocío Alfaro‐Ruiz, Alejandro Martín‐Belmonte, Ricardo Puertas‐Avendaño, Miriam Fernández, María Llanos Martínez-Poyato, Eloy Portero-Campillo, Miguel Pozuelo-Montero, Ana Esther Moreno‐Martínez, Pablo Alonso-Gómez et al. · 2025 · Journal of Alzheimer s Disease
  11. Signaling cascades shape functional subpopulations of cortical astrocytes in male wild-type mice and APP/PS1dE9 Alzheimer’s disease model
    Yiannis Poulot-Becq-Giraudon, Océane Guillemaud, Elisa Degl’Innocenti, Vivien Letenneur, Karouna Bascarane, Tony Barbay, Mie Møller Clausen, Céline Derbois, Martine Guillermier, Ludmila Juricek et al. · 2026 · Nature Communications
  12. Neuropathological and functional impact of astrocyte-derived extracellular vesicles in an aged model of Alzheimer's disease
    Bao Quach, Sahar N Salehi, Rejina Roufegarinejad, Vishal Singh Guleria, Michael Mante, Jazmin B. Florio, Robert A. Rissman, Charisse N. Winston · 2026 · Experimental Neurology
  13. Prolonged systemic inflammation worsens impairments to astrocyte Ca 2+ and functional hyperemia in Alzheimer's disease
    Chang Liu, Kimia Sakha, Juni Anton, Alfredo Cárdenas‐Rivera, Mohammad Abbas Yaseen · 2026 · Alzheimer s & Dementia
  14. Sporadic Alzheimer’s disease animal model using streptozotocin and APP/PS1 mice
    Sally Kelliny, Isaac Bul Deng, Xin‐Fu Zhou, Larisa Bobrovskaya · 2022 · Elsevier eBooks
  15. Neuroplastin 65 deficiency reduces amyloid plaque formation and cognitive deficits in an Alzheimer’s disease mouse model
    Dan-Dan Wu, Jie Cheng, Ya-Ni Zheng, Yu‐Tong Liu, Shuang-Xin Hou, Li-Fen Liu, Liang Huang, Qionglan Yuan · 2023 · Frontiers in Cellular Neuroscience
  16. Wnt Signaling Roles on the Structure and Function of the Central Synapses: Involvement in Alzheimer’s Disease
    C. Nibaldo, Lorena Varela‐Nallar · 2013 · InTech eBooks
  17. Basic aspects in selecting a suitable transgenic rodent model for Alzheimer's disease.
    Ioana Miruna Balmus, Alin Stelian Ciobica, Anca Negură, Lucian Negură, Emil Anton · 2015 · PubMed
  18. Genotype and Sex Differences in Longevity in Transgenic Mouse Models of Alzheimer’s Disease
    Richard E. Brown, Sooyoun Shin, Nicole Woodland, Eric A. Rae · 2018 · Elsevier eBooks
  19. Environmental enrichment as a preventative and therapeutic approach to Alzheimer's disease
    Kimberley E. Stuart, Anna Elizabeth King, James Clement Vickers · 2020 · Elsevier eBooks
  20. Alzheimer disease models and human neuropathology: similarities and diVerences
    Charles J. Duyckaerts, Marie‐Claude Potier, Benoı̂t Delatour · 2008
  21. Antimuscarinics for the treatment of overactive bladder: A review of central nervous system effects
    Adam P. Klausner, William Donald Steers · 2007 · Current Bladder Dysfunction Reports
  22. Real-time imaging of mitochondrial redox reveals increased mitochondrial oxidative stress associated with amyloid β aggregates in vivo in a mouse model of Alzheimer’s disease
    María Calvo-Rodríguez, Elizabeth K. Kharitonova, Austin C. Snyder, Steven S. Hou, Maria Virtudes Sanchez-Mico, Sudeshna Das, Zhanyun Fan, Hamid Shirani, K. Peter R. Nilsson, Alberto Serrano‐Pozo et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  23. Multi-scale Assessment of Brain Blood Volume and Perfusion in the APP/PS1 Mouse Model of Amyloidosis
    Leon P. Munting, Marc Derieppe, Lenard M. Voortman, Artem Khmelinskii, Ernst Suidgeest, Lydiane Hirschler, Emmanuel Barbier, Baudouin Denis de Senneville, Louise van der Weerd · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  24. Microglia determine ß-amyloid plaque burden but are non-essential for downstream pathology
    Mosi Li, Kristján Holt, Katherine Ridley, Jing Qiu, Kirsty Haddow, Deepali Vasoya, Xin He, Jane Tulloch, Declan King, David Arthur Hume et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  25. Neocortical cholinergic pathology after neonatal brain injury is increased by Alzheimer's disease-related genes in mice
    Leslie Doucette, Victoria Turnbill, Katherine Carlin, Andrew S. Cavanagh, Benjamin I. Sollinger, Nazli Kuter, Debra L. Flock, Shenandoah Robinson, Raul Chavez‐Valdez, Lauren L. Jantzie et al. · 2024 · Neurobiology of Disease
  26. Docosahexaenoic acid improves synaptic structure and function in APP/PS1 mice through the TrkB-Erk1/2-CREB pathway
    Nana Bie, Mengdi Yan, Chunling Wang · 2025 · Food Science and Human Wellness
  27. HDAC3 Epigenetic Suppression by Electroacupuncture Restores AMPA Receptor Function and Synaptic Plasticity in Alzheimer’s Disease Models
    Hongzhu Li, Bing Deng, Mucan Lin, Lanfeng Lai, Jiaying Zhao, Yuemei Li · 2025 · NeuroMolecular Medicine
  28. Female‐biased astrocytic priming shapes early locus coeruleus vulnerability in an Aβ oligomer milieu
    Srishti Kushwaha, Rupsa Roy Choudhury, Priyanka Bhat, S. Senthil Kumaran, Smitha Karunakaran · 2026 · Alzheimer s & Dementia
  29. Metformin Restores Innate Fear Deficits in Young Adult Female APP/PS1 Mice via Basolateral Amygdala Activation
    Bin Zhang, Weiming Bian, Kaiyuan Zhu, Yuzhen Dai, Miao Cai, Jiaqi Cheng, Xinyan Chen, Zheng Xiang, Yixiu Liu, Wen Lu · 2026 · Molecular Neurobiology
  30. Fisetin targets multiple signaling pathways to suppress microglia-mediated neuroinflammation and cognitive decline in Alzheimer's disease
    Yu-Ting Dai, Qian Chen, Yan-Dong Ma, Hang Liu, Handan Zheng, Yi-Yi Zhu, Lei Gao, Qin Zhao, Jie-Lin Bai, Yu-Chen Fan et al. · 2026 · Neuropharmacology
  31. Repetitive Mild Traumatic Brain Injury Causes Neuronal Damage in the APP/PS1 Mouse Model of Alzheimer’s Disease Without an Enduring Impact on Amyloid Pathology, Sleep, or Epileptiform Activity
    Jefferey Yue, Victoria Carriquiriborde, Wai Hang Cheng, Taha Yildirim, Jianjia Fan, Sean Tok, Michael Kelly, Cheryl Lea Wellington, Brianne A. Kent · 2026 · Journal of Neurotrauma
  32. Combining Engineered Probe Library with Tiered Screening for the Rational Discovery of Alzheimer’s Diagnostic Probe with an Enhanced Signal-to-Noise Ratio
    Zhenpeng Li, Xueqian Chen, Jiatian Liu, Shanyan Mo, Yanmin Yu, Zaicheng Sun, Xueyun Gao, Dongdong Su · 2026 · Analytical Chemistry
  33. Clustering Properties of Neuronal Ryanodine Receptor 2 and Remodeling in the APP / PS1 Mouse Model of Alzheimer's Disease
    Michelle L. Munro, R T de Silva, Shane M. Ohline, Ei Phyo Khaing, Joan A. Chan, Mohamed F. Ibrahim, Tausi F. Tausi, Wickliffe C. Abraham, Peter P. Jones · 2026 · Acta Physiologica
  34. Steroidal alkaloid H89712 ameliorates neuroinflammation and memory deficits: Enhancing cerebral oxidative phosphorylation in APP/PS1 mice
    Lu Jiang, Zhuo Zhang, Xin Luo, H W Wu, 黄志纯, Wei Wu, Sumei Xu, Jie Pan, Zhirong Tan · 2026 · Life Sciences
  35. Large amyloid plaques associate with early behavioral alterations in 6-month-old APPswe/PS1dE9 mice
    Kseniia Sitdikova, Andrey Tsoy, Kirill Chaprov, Johannes de Munter, Evgeniy P. Svirin, Hamlet Torosyan, Konstantin B. Yenkoyan, Sholpan Askarova, Harry W.M. Steinbusch, Daniel C. Anthony et al. · 2026 · Journal of Neuropathology & Experimental Neurology
  36. Efficacy of Low Dose of Dihydroquercetin (DHQ) in Two Genetic Models of Neurodegeneration: Insights from FUS[1-359]-Tg and APPswe/PS1dE9 Paradigms
    Ekaterina A. Lysikova, Kseniia Sitdikova, Aigerim Makhambetova, Kirill Chaprov, Горлова Анна Вячеславовна, Andrey Kostin, Polina M. Novikova, Alexei Lyundup, Sholpan Askarova, Michail S. Kukharsky et al. · 2026 · Cells
  37. Age-Related Changes in Cognitive, Emotional, and Motor Behaviour in Male and Female 3xTg-AD Mice: A Longitudinal Study
    Kurt R. Stover · 2015 · DalSpace (Dalhousie University)
  38. A light therapy for treating Alzheimer's disease
    Xue Bing Wang, Mengmeng Han, Qiyan Wang, Yuhui Zeng, Qingqiang Meng, Jun Zhang, Xunbin Wei · 2017 · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE
  39. Autophagy Monitoring in Cerebral Pericytes from Alzheimer’s disease Mouse Model in an Inflammatory Environment
    P Guylène · 2022 · Journal of Parkinson’s Disease and Alzheimer’s Disease
  40. An Investigation of the Inflammatory Landscape in the Brain and Bone Marrow of the APP/PS1 Mouse
    Kishore Chittimalli, Stephen Adkins, Sanjay Arora, Jagdish Singh, Yagna P. R. Jarajapu · 2024 · Journal of Alzheimer s Disease Reports
  41. Animal Models of Neurodegenerative Diseases
    Imad Ghorayeb, Guylène Page, Afsaneh Gaillard, Mohamed Jaber · 2010 · Advances in neurobiology
  42. Near infra-red light treatment of Alzheimer’s disease
    Lechan Tao, Xue Wang, Quanqu Zhou, Xunbin Wei · 2019 · Biophotonics and Immune Responses
  43. Tranexamic acid in a mouse model of cerebral amyloid angiopathy: setting the stage for a novel stroke treatment approach
    Zikou Liu, Fiona M. McCutcheon, Heidi Ho, Joanne Shu Ming Chia, Yunxin Xiao, Isabel Tippett, Charithani Bhagya Keragala, Geoffrey C. CLOUD, Robert Lindsay Medcalf · 2023 · Research and Practice in Thrombosis and Haemostasis
  44. Original Research Report Peripherally Administered Human Umbilical Cord Blood Cells Reduce Parenchymal and Vascular -Amyloid Deposits in Alzheimer Mice
    William V. Nikolic, Huayan Hou, Terrence Town, Yuyan Zhu, Brian N. Giunta, Cyndy Davis Sanberg, Jin Zeng, Deyan Luo, Jared C. Ehrhart, Takashi Mori et al. · 2008
  45. The Involvement of Metal Ions in Copper-Zinc Superoxide Dismutase Related Amyotrophic Lateral Sclerosis
    Megan W. Bourassa · 2012 · Academic Commons (Stony Brook University)
  46. WNT SIGNALING IN MICROGLIA
    Carina Halleskog · 2013
  47. Unexpected Early Proteomic Changes in Alzheimer’s Disease Model Mice Synaptosomes
    Kerri A. Ball, Addolorata Pisconti, Kelly M. Grounds, William M. Old, Michael H. B. Stowell · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
  48. Epigenetics in mental and neurodegenerative disorders
    Iatrou · 2018
  49. Automatic Spike-Wave discharge detection within EEG of mice models of human absence epilepsy
    Michal Demjan · 2020 · UEF eRepo (University of Eastern Finland)
  50. Microvascular and blood-brain barrier dysfunction in Alzheimer’s disease
    Harm J. van de Haar · 2016
  51. Long term worsening of Alzheimer pathology and clinical outcome by a single inoculation of mutated beta-amyloid seeds
    Marina Célestine, Muriel R. Jacquier‐Sarlin, Eve Borel, Fanny Petit, J. Pérot, Anne‐Sophie Hérard, Luc Bousset, Alain Buisson, Marc Dhénain · 2022 · Research Square
  52. Ultrasound Induced Blood-brain Barrier Opening on Rodents : from Nanoparticles Delivery to a Therapy for Alzheimer’s Disease
    Matthieu Gerstenmayer · 2018 · theses.fr (ABES)
  53. WNT SIGNALING IN MICROGLIA
    Carina Halleskog · 2013 · Figshare
  54. Efeitos comportamentais e bioquímicos da dieta intermitente na vigência de um estímulo inflamatório no hipocampo de ratos.
    Andréa Rodrigues Vasconcelos · 2011
  55. Epigenetic dysregulation and the pathophysiology of Alzheimer’s disease
    Diego Mastroeni · 2013
  56. Immunomodulation As A Potential Therapeutic Approach For Alzheimer’s Disease
    William V. Nikolic · 2008 · Digital Commons - University of South Florida (University of South Florida)
  57. The effect of dietary omega-3 polyunsaturated fattyacids and curcumin on cognition and pathology in amouse model of amyloid pathology
    Katie Hall · 2011 · ORCA Online Research @Cardiff (Cardiff University)
  58. Multiplexing Techniques in Quantitative Proteomics to Study Disease
    Adam R. Evans · 2015 · D-Scholarship@Pitt (University of Pittsburgh)
  59. Implications of Human Umbilical Cord Blood Cells: An Immunotherapeutic Strategy for Alzheimer's Disease
    Donna Darlington · 2014 · Digital Commons - University of South Florida (University of South Florida)
  60. UBB+1, an important switch in the onset of Alzheimer’s disease
    Romina J. G. Gentier · 2015
  61. Modulation of Alzheimer's Disease Pathology and Neuroplasticity by Environmental Factors
    Yuan‐Shih Hu · 2012 · Figshare
  62. The role of neuronal calcium sensor protein Vilip-1 in Abeta-induced neuronal death in Alzheimer disease
    Caitlin M. Kirkwood · 2015 · D-Scholarship@Pitt (University of Pittsburgh)
  63. Vascular and glial alterations during aging in wild-type mice and along Alzheimer's disease progression in APP/PS1 mice
    Cátia Alexandra da Silva Janota · 2014
  64. In Vitro and In Vivo Studies on Antibodies - N-terminally Truncated Abeta in the 5XFAD Mouse Model
    Bernhard Clemens Richard · 2015
  65. Neuroinflammation in Alzheimer's Disease and Vascular Cognitive Impairment
    Erica M. Weekman · 2017 · UKnowledge (University of Kentucky)
  66. Molecular Mechanisms of Neuroprotection and Cognitive Enhancement by an Alternative drug Centella asiatica
    Manuj Ahuja · 2013
  67. Metaplasticity Tunes Functional Plasticity in the Rodent Hippocampus
    Qin Li · 2015 · Digitale Bibliothek Braunschweig (Verbundzentrale Göttingen (VZG))
  68. C-terminally truncated Amyloid-β peptides in Alzheimer’s dementia: Deposition of Aβ37, Aβ38, and Aβ39 in the brains of patients with sporadic and familiar Alzheimer’s dementia and in transgenic mouse models.
    Jochim Reinert · 2018
  69. DEPLETION OF TDP-43 ACCELERATES NEURODEGENERATION IN AN ALZHEIMER’S MOUSE MODEL, INDEPENDENT OF BETA-AMYLOID PLAQUE BURDEN
    Katherine D. LaClair · 2016
  70. Assessing Cognition In A Mouse Model Of Alzheimer’s Disease
    Justin Mels · 2018 · Scholarship@Western (Western University)
  71. METAPLASTICITY IN A MOUSE MODEL OF ALZHEIMER’S DISEASE AND POSSIBLE THERAPEUTIC INTERVENTIONS
    Andrea Megill · 2014
  72. The Roles of Diffusion and Bulk Flow in Neural Function and Alzheimer's Disease
    Wade N Dauberman · 2017
  73. Urine Is an Ideal Biomarker Resource in Early Detecting Neurodegenerative Diseases
    Jing Wei · 2019 · Springer eBooks
  74. Developing amyloid-β chaperone lipocalin-type prostaglandin D synthase protein as a magnetic resonance active early diagnostic tool
    Bhargy Sharma · 2019
  75. Investigating the role of normal and abnormal beta-amyloid processing in cognition
    Thomas J. Freeman · 2019 · ORCA Online Research @Cardiff (Cardiff University)
  76. Hippocampal field potentials in animal models of Alzheimer's disease
    Arto Lipponen · 2014 · UEF eRepo (University of Eastern Finland)
  77. Ascorbate Deficiency Accelerates Neuropathology in Alzheimer's Disease
    Shilpy Dixit · 2017
  78. EFEITOS COMPORTAMENTAIS E BIOQUÍMICOS DA DIETA INTERMITENTE NA VIGÊNCIA DE UM ESTÍMULO INFLAMATÓRIO NO HIPOCAMPO DE RATOS
    São Paulo · 2011
  79. Far Infrared Light Irradiation Enhances Microglial Aβ Clearance and Ameliorates Cognitive Deficit in Alzheimer’s Disease-like Mice
    Zhi Wang, Qingyong Li, Wensi Wu, Yanan Lu, Jing Wen, Jiaoyan Ren, Huiying Zhao, Zhiyi Zuo · 2020 · Research Square
  80. Angiogenesis
    2013 · Angiogenesis
  81. IMPACTS OF HYPERTENSION AND THROMBOSIS IN A RAT MODEL OF CEREBRAL AMYLOID ANGIOPATHY (rTg-DI)
    Aleksandra Stanisavljevic · 2022
  82. The ubiquitin-proteasome system in neurodegenerative diseases
    Lambertus Verheijen · 2023
  83. Impact of Long-Term Dietary High Fat and Eicosapentaenoic Acid on Behavior and Hypothalamic-Pituitary-Adrenal Axis Activity in Amyloidogenic APPswe/PSEN1dE9 Mice
    Breanna N. Harris, Mahsa Yavari, Latha Ramalingam, Philip Mounce, Kaylee Alers Maldonado, Angela Chavira, Sarah Thomas, Shane O. Scoggin, Caroline Biltz, Naïma Moustaïd‐Moussa · 2024 · Neuroendocrinology
  84. Revealing hidden knowledge in amnestic mice
    Andrea Santi, Sharlen Moore, Kelly A. Fogelson, Aaron H. Wang, Jennifer Lawlor, Jordan Amato, Kali Burke, Amanda M. Lauer, Kishore V. Kuchibhotla · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  85. Urine Proteome Application in Neurodegenerative Diseases Biomarker Discovery
    Jing Wei, Mindi Zhao, Yameng Zhang, Lujun Li · 2025 · Springer eBooks
  86. Proactive Interference Unmasks Sex-Divergent Recognition Memory Instability and Catecholaminergic Dysfunction in Early-Stage Alzheimer’s model
    Srishti Kushwaha, Rupsa Roy Choudhury, Smitha Karunakaran · 2025 · Research Square
  87. Sex-dependent effect of amyloidosis on functional network ‘hub’ topology is associated with downregulated neuronal gene signatures in the APP swe /PSEN1dE9 double transgenic mouse
    Zachary D Simon, Karen N. McFarland, Todd Eliot Golde, Paramita Chakrabarty, Marcelo Febo · 2025 · Journal of Alzheimer s Disease
  88. TREK1 upregulation is an endogenous mechanism delaying cognitive decline in Alzheimer’s Disease
    Tuhina Mitra, Ranjit Bhoi, Triparna Chakraborty, Asmit Moharana, Vaishnav Manoj, Hiral Rawal, Swagata Ghatak · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  89. Impaired prepulse inhibition in APP/PS1 mice is accompanied by substantial morphological changes in neurons of the central auditory system and hippocampus
    Jana Svobodova Burianova, Daniela Černotová, Tereza Klausová, Oliver Profant, Jakub Fuksa, Josef Syka, Jan Svoboda · 2025 · Hearing Research
  90. Additional file 2 of Behavioral and electrophysiological evidence for a neuroprotective role of aquaporin-4 in the 5xFAD transgenic mice model
    Abe, Yoichiro, Natsumi Ikegawa, Yoshida, Keitaro, Kyosuke Muramatsu, Hattori, Satoko, Kenji Kawai, Minetaka Murakami, Tanaka, Takumi, Wakami Goda, Goto, Motohito et al. · 2020 · Figshare
  91. Additional file 1 of Dexibuprofen ameliorates peripheral and central risk factors associated with Alzheimer’s disease in metabolically stressed APPswe/PS1dE9 mice
    Miren Ettcheto, Elena Sánchez‐López, Cano, Amanda, Carrasco, Marina, Katherine Herrera, Manzine, Patricia R., Triana Espinosa-Jiménez, Busquets, Oriol, Verdaguer, Ester, Jordi Olloquequi et al. · 2021 · Figshare
  92. Additional file 1 of Comparing regional brain uptake of incretin receptor agonists after intranasal delivery in CD-1 mice and the APP/PS1 mouse model of Alzheimer’s disease
    Abdulhameed, Noor, Alice Babin, Hansen, Kim, Riley R. Weaver, William A. Banks, Konrad Talbot, Elizabeth M. Rhea · 2024 · Figshare
  93. Additional file 11 of Behavioral and electrophysiological evidence for a neuroprotective role of aquaporin-4 in the 5xFAD transgenic mice model
    Abe, Yoichiro, Natsumi Ikegawa, Yoshida, Keitaro, Kyosuke Muramatsu, Hattori, Satoko, Kenji Kawai, Minetaka Murakami, Tanaka, Takumi, Wakami Goda, Goto, Motohito et al. · 2020 · Figshare
  94. Additional file 3 of Retinal capillary degeneration and blood-retinal barrier disruption in murine models of Alzheimer’s disease
    Shi, Haoshen, Yosef Koronyo, Fuchs, Dieu-Trang, Julia Sheyn, Kolja Wawrowsky, Shouri Lahiri, Black, Keith L., Maya Koronyo‐Hamaoui · 2020 · Figshare
  95. Additional file 1 of Pathological changes induced by Alzheimer’s brain inoculation in amyloid-beta plaque-bearing mice
    Suzanne Lam, Anne‐Sophie Hérard, Susana Boluda, Fanny Petit, Sabiha Eddarkaoui, Karine Cambon, Jean‐Luc Picq, Luc Buée, Charles J. Duyckaerts, Stéphane Haı̈k et al. · 2022 · Figshare
  96. Additional file 3 of Comparing regional brain uptake of incretin receptor agonists after intranasal delivery in CD-1 mice and the APP/PS1 mouse model of Alzheimer’s disease
    Abdulhameed, Noor, Alice Babin, Hansen, Kim, Riley R. Weaver, William A. Banks, Konrad Talbot, Elizabeth M. Rhea · 2024 · Figshare
  97. Additional file 2 of Comparing regional brain uptake of incretin receptor agonists after intranasal delivery in CD-1 mice and the APP/PS1 mouse model of Alzheimer’s disease
    Abdulhameed, Noor, Alice Babin, Hansen, Kim, Riley R. Weaver, William A. Banks, Konrad Talbot, Elizabeth M. Rhea · 2024 · Figshare
  98. Additional file 1 of Behavioral and electrophysiological evidence for a neuroprotective role of aquaporin-4 in the 5xFAD transgenic mice model
    Abe, Yoichiro, Natsumi Ikegawa, Yoshida, Keitaro, Kyosuke Muramatsu, Hattori, Satoko, Kenji Kawai, Minetaka Murakami, Tanaka, Takumi, Wakami Goda, Goto, Motohito et al. · 2020 · Figshare
  99. Additional file 1 of Collusion of α-Synuclein and Aβ aggravating co-morbidities in a novel prion-type mouse model
    Grace M. Lloyd, Dhillon, Jess-Karan S., Gorion, Kimberly-Marie M., Cara J. Riffe, Susan Fromholt, Yuxing Xia, Benoit I. Giasson, Borchelt, David R. · 2021 · Figshare
  100. Additional file 12 of Behavioral and electrophysiological evidence for a neuroprotective role of aquaporin-4 in the 5xFAD transgenic mice model
    Abe, Yoichiro, Natsumi Ikegawa, Yoshida, Keitaro, Kyosuke Muramatsu, Hattori, Satoko, Kenji Kawai, Minetaka Murakami, Tanaka, Takumi, Wakami Goda, Goto, Motohito et al. · 2020 · Figshare